The Food and Drug Administration today recommended medical device manufacturers, health care providers and patients take certain actions to reduce the risk that a remote attacker could exploit a set of cybersecurity vulnerabilities to control a medical device or prevent it from functioning. The agency to date has not received any adverse event reports associated with the vulnerabilities, announced in a July advisory from the Department of Homeland Security. The vulnerabilities exist in IPnet, a third-party software component that supports network communications between computers. The software is part of several operating systems and may be used in a wide range of medical and industrial devices.
 

Headline
The Food and Drug Administration has issued a Class I recall correction for certain Boston Scientific ACCOLADE pacemakers and cardiac resynchronization therapy…
Headline
Microsoft Threat Intelligence is warning of a large scale, multistage phishing campaign that disproportionately targeted the health care sector, sending “code…
Headline
The Cybersecurity and Infrastructure Security Agency has launched a new initiative for critical infrastructure to defend against cyberattacks through proactive…
Headline
John Riggi, AHA national advisor for cybersecurity and risk, will moderate a webinar May 5 at 1 p.m. ET that will explore how bad actors are leveraging…
Headline
The AHA and Joint Commission May 4 announced the launch of the Cyber Resilience Readiness program, an initiative to help hospitals and health systems assess…
Headline
The Cybersecurity and Infrastructure Security Agency, National Security Agency and international partners have released guidance on adopting agentic artificial…